Medista Pharma Private Limited, a active private limited company, was established on 22 August 2020 in Gandipet, Telangana, India. Engaging in eye care & ophthalmology clinics within the trade sector, it holds CIN: U51909TG2020PTC143094. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Rajesh Kumar Srivastava (Director), Vinita Srivastava (Director), Subramanian Pulayarpatti Lakshmanan (Director). Past directors included Rajesh Kumar Srivastava. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 8/P, Sri Sai Nagar Kismathpur Gandipet Mandal, Gandipet, Telangana, 500086.
U51909TG2020PTC143094
143094
22 August 2020
₹1.00 M
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Medista Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Kumar Srivastava | Director | 15 Sep 2020 | Current |
| Vinita Srivastava | Director | 22 Aug 2020 | Current |
| Subramanian Pulayarpatti Lakshmanan | Director | 22 Aug 2020 | Current |
| Suresh Kumar Makineedi | Director | 22 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medista Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.27% increase. The company also saw a substantial improvement in profitability, with a 69.74% increase in profit. The company's net worth Soared by an impressive increase of 21.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medista Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Medista Pharma has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medista Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medista Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Medista Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Medista Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity Rajesh Kumar Srivastava was appointed as a Director was appointed as a Director on 15 Sep 2020 & has been associated with this company since 5 years 2 months . was completed.
Vinita Srivastava was appointed as a Director was appointed as a Director on 22 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
Subramanian Pulayarpatti Lakshmanan was appointed as a Director was appointed as a Director on 22 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
Suresh Kumar Makineedi was appointed as a Director was appointed as a Director on 22 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
The CIN of Medista Pharma Private Limited is U51909TG2020PTC143094.
Medista Pharma Private Limited is headquartered at Plot No 8/P, Sri Sai Nagar Kismathpur Gandipet Mandal, Gandipet, Telangana, 500086.
Medista Pharma Private Limited was incorporated on 22 August 2020.
The current directors of Medista Pharma Private Limited are
The primary industry of Medista Pharma Private Limited is Trade.
Medista Pharma Private Limited is unlisted.
The authorized capital of Medista Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Medista Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX